Genetic Variations of Tyrosine Hydroxylase in the Pathogenesis of Hypertension.

Q3 Medicine
Electrolyte and Blood Pressure Pub Date : 2016-12-01 Epub Date: 2016-12-31 DOI:10.5049/EBP.2016.14.2.21
Yu Ho Lee, Yang Gyun Kim, Ju-Young Moon, Jin Sug Kim, Kyung-Hwan Jeong, Tae Won Lee, Chun-Gyoo Ihm, Sang Ho Lee
{"title":"Genetic Variations of Tyrosine Hydroxylase in the Pathogenesis of Hypertension.","authors":"Yu Ho Lee,&nbsp;Yang Gyun Kim,&nbsp;Ju-Young Moon,&nbsp;Jin Sug Kim,&nbsp;Kyung-Hwan Jeong,&nbsp;Tae Won Lee,&nbsp;Chun-Gyoo Ihm,&nbsp;Sang Ho Lee","doi":"10.5049/EBP.2016.14.2.21","DOIUrl":null,"url":null,"abstract":"<p><p>One of the major pathophysiological features of primary hypertension is an inappropriate activation of the sympathetic nervous system, which is mediated by excessive synthesis and secretion of catecholamine into the blood. Tyrosine hydroxylase (TH), a rate-limiting enzyme in the synthesis of catecholamine, has been highlighted because genetic variations of <i>TH</i> could alter the activity of the sympathetic nervous system activity and subsequently contribute to the pathogenesis of hypertension. Here, we discuss the role of TH as a regulator of sympathetic activity and review several studies that investigated the relationship between genetic variations of <i>TH</i> and hypertension.</p>","PeriodicalId":35352,"journal":{"name":"Electrolyte and Blood Pressure","volume":"14 2","pages":"21-26"},"PeriodicalIF":0.0000,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5049/EBP.2016.14.2.21","citationCount":"9","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Electrolyte and Blood Pressure","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5049/EBP.2016.14.2.21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2016/12/31 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 9

Abstract

One of the major pathophysiological features of primary hypertension is an inappropriate activation of the sympathetic nervous system, which is mediated by excessive synthesis and secretion of catecholamine into the blood. Tyrosine hydroxylase (TH), a rate-limiting enzyme in the synthesis of catecholamine, has been highlighted because genetic variations of TH could alter the activity of the sympathetic nervous system activity and subsequently contribute to the pathogenesis of hypertension. Here, we discuss the role of TH as a regulator of sympathetic activity and review several studies that investigated the relationship between genetic variations of TH and hypertension.

Abstract Image

酪氨酸羟化酶在高血压发病机制中的遗传变异。
原发性高血压的主要病理生理特征之一是交感神经系统的不适当激活,这是由过量的儿茶酚胺合成和分泌到血液中介导的。酪氨酸羟化酶(Tyrosine hydroxylase, TH)是儿茶酚胺合成中的一种限速酶,由于TH的遗传变异可能改变交感神经系统的活性,从而导致高血压的发病机制,因此被强调。在这里,我们讨论了TH作为交感神经活动的调节者的作用,并回顾了一些研究TH遗传变异与高血压之间关系的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Electrolyte and Blood Pressure
Electrolyte and Blood Pressure Medicine-Internal Medicine
CiteScore
2.10
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信